SecBot SecBot
144 ·Filed May 1, 2026

MBX

MBX Biosciences, Inc.
BEARISH
Impact 5/10
Horizondays Processed5mo ago SEC0001959173-26-003192
Form 144 — notice of proposed sale of securities
Actionable Insight ▼ Bearish

The insider's persistent selling warrants caution. Watch for further Form 144 or Form 4 filings; a cessation of sales could stabilize sentiment.

DirectionBearish
Confidencemedium
Horizondays
Final — all horizons settled through T+60d
MBX ▲ +101.68% at T+60d
SHORT call ✗ call lost -101.68% · α vs SPY -98.61% · entry $29.78 → $60.06
Entry = T+0 close
May 1, 2026
via day close
T+1d
-1.14%
call +1.14% · α +0.80%
$29.44
settled 6mo ago
T+5d
+16.55%
call -16.55% · α -14.21%
$34.71
settled 6mo ago
T+20d
+2.92%
call -2.92% · α +2.36%
$30.65
settled 5mo ago
T+60d
+101.68%
call -101.68% · α -98.61%
$60.06
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Former officer Richard Bartram files Form 144 to sell 5,000 MBX shares (~$159k), adding to 21,484 shares already sold in the prior two months. The consistent insider selling pattern raises concerns about confidence in the company's near-term outlook.

Key Facts

  • Bartram Richard, a former officer, filed Form 144 to sell 5,000 shares of common stock.
  • Estimated market value of proposed sale is $159,000.
  • Sold 21,484 shares in three prior transactions since mid-March 2026.
  • Total insider disposition over ~2 months: 26,484 shares.

Financial Impact

Proposed sale of 5,000 shares valued at ~$159k; cumulative insider sales ~$830k over 2 months.

Risk Factors

  • Continued insider selling may signal weakening confidence in MBX's fundamentals.
  • Potential negative market perception of insider distribution pattern.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
87% bullish (15 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-003192
Document: 0001959173-26-003192-index.html0001959173-26-003192
Document: 0001959173-26-003192.txt0001959173-26-003192
27 reports for MBX
Performance horizon
67% Hit rate @ T+1 6 of 9 directional calls Went positive at some point 7 of 9 best @ T+60▲ +85.57%May 7, 2026
Filters
Rows
Reports for MBX — sortable, filterable
TypeNow
Oct 22, 2026
4d ago
3
NEUTRAL ★ 2/10
$50.46 $48.50▼ −3.88%▼ −3.36%$50.29 (−0.34%)
Oct 22, 2026
4d ago
8-K
NEUTRAL ★ 2/10
$50.46 $48.50▼ −3.88%▼ −3.36%$50.29 (−0.34%)
Aug 27, 2026
8w ago
Press Release
BULLISH ★ 8/10
$66.39 $63.00▼ −5.11%▼ −4.88%$50.29 (−24.25%)
Aug 17, 2026
10w ago
144
NEUTRAL ★ 3/10
$68.25 $66.52▼ −2.53%▼ −1.86%$50.29 (−26.32%)
Aug 6, 2026
11w ago
8-K
BULLISH ★ 7/10
$67.11 $67.82▲ +1.06%▲ +0.45%$50.29 (−25.06%)
Jun 12, 2026
19w ago
8-K
BULLISH ★ 7/10
$35.51 $38.98▲ +9.77%▲ +8.01%$50.29 (+41.62%)
Jun 12, 2026
19w ago
Press Release
BULLISH ★ 6/10
$35.51 $38.98▲ +9.77%▲ +8.01%$50.29 (+41.62%)
Jun 11, 2026
19w ago
Institutional Cluster
BULLISH ★ 5/10
$37.25 $35.51▼ −4.67%▼ −5.21%$50.29 (+35.01%)
Jun 11, 2026
19w ago
Institutional Cluster
NEUTRAL ★ 3/10
$37.25 $35.51▼ −4.67%▼ −5.21%$50.29 (+35.01%)
Jun 10, 2026
19w ago
144
NEUTRAL ★ 2/10
$30.99 $37.25▲ +20.20%▲ +18.50%$50.29 (+62.28%)
Showing 10 of 27

US Market Status

Market Closed — Opens Tue (16h 38m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 1, 2026